Back

Subclinical myocardial impairment in treatment-naive cancer patients assessed by cardiac magnetic resonance

21 June 2025 (13:00 - 14:00)
Organised by: Logo
Congress Presentation Part of: Imaging innovations in cardio-oncology Diagnosis and Management of Cardiovascular Disease in Patients with Cancer CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Doctor Stefano Figliozzi

Humanitas Research Hospital, Rozzano (Italy)

8 More presentations in this session

Presentation thumbnail
Vascular inflammation in patients undergoing CD19 chimeric antigen receptor (CAR)-T cells for hematologic malignancies: a call for cardiovascular surveillance.
Doctor M. Camilli (Rome, IT)
Abstract Slides
Presentation thumbnail
Echocardiographic changes in the right ventricle during chemotherapy - a systematic review and meta-analysis
Doctor E. Sant Anna Melo (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Relationship between cardiovascular dysfunction and weight loss in patients with esophageal cancer: results from a Cardiac MRI-Based Study
Doctor Z. Drobni (Budapest, HU)
Abstract Slides
Presentation thumbnail
Myocardial work as a tool for detecting subclinical cardiac dysfunction related to cancer therapy
Doctor C. Contaldi (Naples, IT)
Abstract Slides
Presentation thumbnail
Cardiovascular toxicity surveillance in metastatic breast cancer patients receiving long-term HER2-targeted therapy: a retrospective multicentre study
Doctor B. Dowsing (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Imaging innovations in cardio-oncology

The Event

Event poster

ESC Cardio-Oncology 2025

21 June 2025 13:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources